| #31 |
Venkat R. Thalladi |
Theravance Biopharma R&D Ip |
4 |
| #52 |
Kenneth Huang Young |
Konica Minolta Laboratory U.S.A. |
3 |
| #52 |
Paul C. Ning |
Groupon |
3 |
| #52 |
Jing Wu |
Oracle |
3 |
| #52 |
Xiadong Mao |
Sony |
3 |
| #52 |
Michael P. Arend |
Fibrogen |
3 |
| #52 |
Hitoshi Harada |
Emc Ip Holding Company |
3 |
| #52 |
Sreekanth Sreedhararaj |
Walmart Apollo |
3 |
| #52 |
Rao Kolluri |
Rigel Pharmaceuticals |
3 |
| #52 |
Vahid Zia |
Gilead Sciences |
3 |
| #52 |
Wenjin Yang |
Stanford University |
3 |
| #52 |
Attila Vass |
Sony |
3 |
| #52 |
Prem Krish |
Energy Recovery |
3 |
| #52 |
Utsaw Kumar |
Intel |
3 |
| #52 |
Sumedh Thakar |
Qualys |
3 |
| #52 |
Lawrence Chang |
Google |
3 |
| #52 |
Guoxian Wu |
Plexxikon |
3 |
| #52 |
Mark S. Smyth |
Onyx Therapeutics |
3 |
| #52 |
Joey Wong |
RTX (Raytheon) |
3 |
| #52 |
Elhum Amjadi |
Microsoft |
3 |
| #52 |
Stephane J. Jenne |
Codexis |
3 |
| #52 |
Yafan Lu |
Gilead Sciences |
3 |
| #52 |
Simon Hurry |
Visa |
3 |
| #52 |
David Kung |
Power Integrations |
3 |
| #75 |
Craig O'Connell |
Visa |
2 |
| #75 |
Caroline Le Moigne |
Sederma, S.A.S. |
2 |
| #75 |
Rachna Singh |
Salesforce |
2 |
| #75 |
Ketki Ashok Dhamnaskar |
Ra Pharmaceuticals |
2 |
| #75 |
Scott Alan Wolckenhauer |
Gilead Pharmasset |
2 |
| #75 |
Jason Liu |
Thermo Fisher |
2 |
| #75 |
Shantnu Singh |
Visa |
2 |
| #75 |
Vladimir Ofitserov |
Google |
2 |
| #75 |
Ankur S. Tyagi |
Qualys |
2 |
| #75 |
Richard Mark Ramsden |
Walmart Apollo |
2 |
| #75 |
Trudy Hill |
Visa |
2 |
| #75 |
Kiushan Pirzadeh |
Visa |
2 |
| #75 |
Venkata Ramana Murthy Kosuri |
Oracle |
2 |
| #75 |
Xiaolin Hao |
Amgen |
2 |
| #75 |
Varun Sharma |
Asm Ip Holding B.V. |
2 |
| #75 |
Leslie L. Dunston |
Authentic8 |
2 |
| #75 |
Haidong Shao |
Google |
2 |
| #75 |
Energy Cruse, II |
Intuitive Surgical |
2 |
| #75 |
Fang Wang |
Gilead Pharmasset |
2 |
| #75 |
Stephan Jenne |
Codexis |
2 |
| #75 |
Qinglin Meng |
Columbia University |
2 |
| #75 |
John Kolen |
Electronic Arts |
2 |
| #75 |
Chong Han |
Genentech |
2 |
| #75 |
Daniel H. Byun |
Gilead Sciences |
2 |
| #75 |
Vikal Kumar Jain |
Sling Media L.L.C. |
2 |
| #75 |
Elena S. Koltun |
Revolution Medicines |
2 |